International Policy DigestWhen Gene Editing is OkayInternational Policy DigestWhen I organized a series of expert discussion seminars on synthetic biology in 2017 with an aim to apprise the Convention on Biological Diversity and its Cartagena Protocol… Continue reading
International Policy DigestWhen Gene Editing is OkayInternational Policy DigestWhen I organized a series of expert discussion seminars on synthetic biology in 2017 with an aim to apprise the Convention on Biological Diversity and its Cartagena Protocol… Continue reading
BioEdgeCRISPR on the rampageBioEdgeCRISPR on the rampage. by Michael Cook | 14 Apr 2018 | Link. CRISPR gene editing is one of the most exciting technologies of recent years, although most of the excitement so far involves curing people of obscure disea… Continue reading
BioEdgeCRISPR on the rampageBioEdgeCRISPR on the rampage. by Michael Cook | 14 Apr 2018 | Link. CRISPR gene editing is one of the most exciting technologies of recent years, although most of the excitement so far involves curing people of obscure disea… Continue reading
Bone marrow and stem cell drive next weekAlpena NewsThere will be a bone marrow and stem cell drive from 9 a.m.-5 p.m. Thursday at the Alpena Community College Besser Technical Center room 109. Event organizer Emily Lozen said she started the event aft… Continue reading
Bone marrow and stem cell drive next weekAlpena NewsThere will be a bone marrow and stem cell drive from 9 a.m.-5 p.m. Thursday at the Alpena Community College Besser Technical Center room 109. Event organizer Emily Lozen said she started the event aft… Continue reading
Barron’sAveXis Sale: An $8.7 Billion Endorsement for Gene TherapyBarron’sReview | Preview. Last Monday may have been validation day for replacement gene therapy—a promising biotechnology treatment for some diseases that substitutes healthy genes for di… Continue reading
Targeted OncologyAdoptive Immunotherapy Makes Inroads in Head and Neck Cancers, But Challenges RemainTargeted OncologyEarly data on adoptive immunotherapy in head and neck cancers have shown just modest responses. However, they provide proof-of-concept… Continue reading